How important is understanding the tumour microenvironment in treating CLL?
Overview of the T-SPOT assay for diagnosing tuberculosis and cytomegalovirus
A Pharmacist's view on biosimilars
The use of CD20 antibodies in CLL patients with Notch1 mutations
Highlights from the International Workshop of the German CLL Study Group